BVS Relative Valuation
BVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BVS is overvalued; if below, it's undervalued.
Historical Valuation
Bioventus Inc (BVS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 22.56. The fair price of Bioventus Inc (BVS) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：7.62
Fair
9.83
PE
1Y
3Y
5Y
Trailing
Forward
6.81
EV/EBITDA
Bioventus Inc. (BVS) has a current EV/EBITDA of 6.81. The 5-year average EV/EBITDA is 8.87. The thresholds are as follows: Strongly Undervalued below 4.80, Undervalued between 4.80 and 6.84, Fairly Valued between 10.91 and 6.84, Overvalued between 10.91 and 12.95, and Strongly Overvalued above 12.95. The current Forward EV/EBITDA of 6.81 falls within the Undervalued range.
7.49
EV/EBIT
Bioventus Inc. (BVS) has a current EV/EBIT of 7.49. The 5-year average EV/EBIT is 11.28. The thresholds are as follows: Strongly Undervalued below 3.92, Undervalued between 3.92 and 7.60, Fairly Valued between 14.96 and 7.60, Overvalued between 14.96 and 18.64, and Strongly Overvalued above 18.64. The current Forward EV/EBIT of 7.49 falls within the Undervalued range.
0.85
PS
Bioventus Inc. (BVS) has a current PS of 0.85. The 5-year average PS is 0.90. The thresholds are as follows: Strongly Undervalued below 0.02, Undervalued between 0.02 and 0.46, Fairly Valued between 1.34 and 0.46, Overvalued between 1.34 and 1.78, and Strongly Overvalued above 1.78. The current Forward PS of 0.85 falls within the Historic Trend Line -Fairly Valued range.
5.77
P/OCF
Bioventus Inc. (BVS) has a current P/OCF of 5.77. The 5-year average P/OCF is 3.28. The thresholds are as follows: Strongly Undervalued below -40.59, Undervalued between -40.59 and -18.66, Fairly Valued between 25.21 and -18.66, Overvalued between 25.21 and 47.15, and Strongly Overvalued above 47.15. The current Forward P/OCF of 5.77 falls within the Historic Trend Line -Fairly Valued range.
5.37
P/FCF
Bioventus Inc. (BVS) has a current P/FCF of 5.37. The 5-year average P/FCF is 5.81. The thresholds are as follows: Strongly Undervalued below -10.69, Undervalued between -10.69 and -2.44, Fairly Valued between 14.05 and -2.44, Overvalued between 14.05 and 22.30, and Strongly Overvalued above 22.30. The current Forward P/FCF of 5.37 falls within the Historic Trend Line -Fairly Valued range.
Bioventus Inc (BVS) has a current Price-to-Book (P/B) ratio of 3.05. Compared to its 3-year average P/B ratio of 2.41 , the current P/B ratio is approximately 26.47% higher. Relative to its 5-year average P/B ratio of 2.55, the current P/B ratio is about 19.94% higher. Bioventus Inc (BVS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.07%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 1.60% , the current FCF yield is about -100.00% lower.
3.07
P/B
Median3y
2.41
Median5y
2.55
10.55
FCF Yield
Median3y
1.07
Median5y
1.60
Competitors Valuation Multiple
The average P/S ratio for BVS's competitors is , providing a benchmark for relative valuation. Bioventus Inc Corp (BVS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -0.23%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BVS decreased by 27.43% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 20.55 to 49.62.
The secondary factor is the Revenue Growth, contributed -0.23%to the performance.
Overall, the performance of BVS in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Bioventus Inc (BVS) currently overvalued or undervalued?
What is Bioventus Inc (BVS) fair value?
How does BVS's valuation metrics compare to the industry average?
What is the current P/B ratio for Bioventus Inc (BVS) as of Dec 05 2025?
What is the current FCF Yield for Bioventus Inc (BVS) as of Dec 05 2025?
What is the current Forward P/E ratio for Bioventus Inc (BVS) as of Dec 05 2025?